Parathyroid hormone 1-84 (Kerun Biopharmaceutical)

重组人甲状旁腺素1-84（重庆科润生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameParathyroid hormone 1-84 (Kerun Biopharmaceutical)
Drug Alias Name注射用重组人甲状旁腺素(1-84)（重庆科润生物）rhPTH (1-84) (Kerun Biopharmaceutical)Recombinant human parathyroid hormone (PTH) 1-84 (Kerun Biopharmaceutical)Recombinant Human Parathytoid Hormone(1-84) (Kerun Biopharmaceutical)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionParathyroid hormone receptor agonistsOsteogenesis stimulants
TargetsParathyroid hormone receptor
Therapy Area/IndicationsHypoparathyroidismOsteoporosis, Postmenopausal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesHungary +[5] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesChongqing Kerun Biologic Pharmaceutical Development Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesChongqing Kerun Biologic Pharmaceutical Development Co Ltd
Inactive CompaniesShireAarhus University
Active IndicationsOsteoporosis, Postmenopausal
Inactive IndicationsHypoparathyroidism

Other Information

ATC CodeN/A
Related LinksN/A